Mc Guire Investment Group, LLC Abb Vie Inc. Transaction History

Mc Guire Investment Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	BUY	$132.51 - $164.9 $21,466 - $26,713	162 Added 11.08%	1,624 $218,000
Q1 2023 Apr 20, 2023	BUY	$144.61 - $166.54 $4,627 - $5,329	32 Added 2.24%	1,462 $232,000
Q4 2022 Jan 10, 2023	BUY	$138.31 - $165.87 $197,783 - $237,194	1,430 New	1,430 $0
Q1 2022 Apr 14, 2022	BUY	$131.98 - $163.75 $2,243 - $2,783	17 Added 1.14%	1,507 $244,000
Q4 2021 Jan 13, 2022	BUY	$107.43 - $135.93 $160,070 - $202,535	1,490 New	1,490 $202,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Mc Guire Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Mc Guire Investment Group, LLC with notifications on news.